271 related articles for article (PubMed ID: 15070752)
1. Phenotypic effects of leptin replacement on morbid obesity, diabetes mellitus, hypogonadism, and behavior in leptin-deficient adults.
Licinio J; Caglayan S; Ozata M; Yildiz BO; de Miranda PB; O'Kirwan F; Whitby R; Liang L; Cohen P; Bhasin S; Krauss RM; Veldhuis JD; Wagner AJ; DePaoli AM; McCann SM; Wong ML
Proc Natl Acad Sci U S A; 2004 Mar; 101(13):4531-6. PubMed ID: 15070752
[TBL] [Abstract][Full Text] [Related]
2. Changes in insulin sensitivity during leptin replacement therapy in leptin-deficient patients.
Paz-Filho G; Esposito K; Hurwitz B; Sharma A; Dong C; Andreev V; Delibasi T; Erol H; Ayala A; Wong ML; Licinio J
Am J Physiol Endocrinol Metab; 2008 Dec; 295(6):E1401-8. PubMed ID: 18854428
[TBL] [Abstract][Full Text] [Related]
3. Effect of leptin replacement on brain structure in genetically leptin-deficient adults.
Matochik JA; London ED; Yildiz BO; Ozata M; Caglayan S; DePaoli AM; Wong ML; Licinio J
J Clin Endocrinol Metab; 2005 May; 90(5):2851-4. PubMed ID: 15713712
[TBL] [Abstract][Full Text] [Related]
4. Congenital leptin deficiency: diagnosis and effects of leptin replacement therapy.
Paz-Filho G; Mastronardi C; Delibasi T; Wong ML; Licinio J
Arq Bras Endocrinol Metabol; 2010 Nov; 54(8):690-7. PubMed ID: 21340154
[TBL] [Abstract][Full Text] [Related]
5. Ten years of leptin replacement therapy.
Paz-Filho G; Wong ML; Licinio J
Obes Rev; 2011 May; 12(5):e315-23. PubMed ID: 21410864
[TBL] [Abstract][Full Text] [Related]
6. Human leptin deficiency caused by a missense mutation: multiple endocrine defects, decreased sympathetic tone, and immune system dysfunction indicate new targets for leptin action, greater central than peripheral resistance to the effects of leptin, and spontaneous correction of leptin-mediated defects.
Ozata M; Ozdemir IC; Licinio J
J Clin Endocrinol Metab; 1999 Oct; 84(10):3686-95. PubMed ID: 10523015
[TBL] [Abstract][Full Text] [Related]
7. Fat and energy partitioning: longitudinal observations in leptin-treated adults homozygous for a Lep mutation.
Heymsfield SB; Fong TM; Gantz I; Erondu N
Obesity (Silver Spring); 2006 Feb; 14(2):258-65. PubMed ID: 16571851
[TBL] [Abstract][Full Text] [Related]
8. Recombinant methionyl human leptin therapy in replacement doses improves insulin resistance and metabolic profile in patients with lipoatrophy and metabolic syndrome induced by the highly active antiretroviral therapy.
Lee JH; Chan JL; Sourlas E; Raptopoulos V; Mantzoros CS
J Clin Endocrinol Metab; 2006 Jul; 91(7):2605-11. PubMed ID: 16636130
[TBL] [Abstract][Full Text] [Related]
9. Circadian and ultradian rhythm and leptin pulsatility in adult GH deficiency: effects of GH replacement.
Ahmad AM; Guzder R; Wallace AM; Thomas J; Fraser WD; Vora JP
J Clin Endocrinol Metab; 2001 Aug; 86(8):3499-506. PubMed ID: 11502770
[TBL] [Abstract][Full Text] [Related]
10. A new missense mutation in the leptin gene causes mild obesity and hypogonadism without affecting T cell responsiveness.
Fischer-Posovszky P; von Schnurbein J; Moepps B; Lahr G; Strauss G; Barth TF; Kassubek J; Mühleder H; Möller P; Debatin KM; Gierschik P; Wabitsch M
J Clin Endocrinol Metab; 2010 Jun; 95(6):2836-40. PubMed ID: 20382689
[TBL] [Abstract][Full Text] [Related]
11. Effect of three treatment schedules of recombinant methionyl human leptin on body weight in obese adults: a randomized, placebo-controlled trial.
Zelissen PM; Stenlof K; Lean ME; Fogteloo J; Keulen ET; Wilding J; Finer N; Rössner S; Lawrence E; Fletcher C; McCamish M;
Diabetes Obes Metab; 2005 Nov; 7(6):755-61. PubMed ID: 16219020
[TBL] [Abstract][Full Text] [Related]
12. A polymorphic marker in the leptin gene associated with Japanese morbid obesity.
Ohshiro Y; Ueda K; Nishi M; Ishigame M; Wakasaki H; Kawashima H; Furuta H; Sasaki H; Sanke T; Takasu N; Nanjo K
J Mol Med (Berl); 2000; 78(9):516-20. PubMed ID: 11140377
[TBL] [Abstract][Full Text] [Related]
13. Effects of biliopancreatic diversion on diurnal leptin, insulin and free fatty acid levels.
Raffaelli M; Iaconelli A; Nanni G; Guidone C; Callari C; Fernandez Real JM; Bellantone R; Mingrone G
Br J Surg; 2015 May; 102(6):682-90. PubMed ID: 25808987
[TBL] [Abstract][Full Text] [Related]
14. Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine/metabolic dysfunction of human congenital leptin deficiency.
Farooqi IS; Matarese G; Lord GM; Keogh JM; Lawrence E; Agwu C; Sanna V; Jebb SA; Perna F; Fontana S; Lechler RI; DePaoli AM; O'Rahilly S
J Clin Invest; 2002 Oct; 110(8):1093-103. PubMed ID: 12393845
[TBL] [Abstract][Full Text] [Related]
15. Leptin concentrations do not correlate with fat mass nor with metabolic risk factors in morbidly obese females.
García-Lorda P; Bulló M; Vilà R; del Mar Grasa M; Alemany M; Salas-Salvadó J
Diabetes Nutr Metab; 2001 Dec; 14(6):329-36. PubMed ID: 11853365
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic use of recombinant methionyl human leptin.
Vatier C; Gautier JF; Vigouroux C
Biochimie; 2012 Oct; 94(10):2116-25. PubMed ID: 22464954
[TBL] [Abstract][Full Text] [Related]
17. [Evaluation of leptin levels in plasma and their reliance on other hormonal factors affecting tissue fat levels in people with various levels of endogenous cotisol].
Robaczyk MG
Ann Acad Med Stetin; 2002; 48():283-300. PubMed ID: 14601484
[TBL] [Abstract][Full Text] [Related]
18. Rapid improvement of hepatic steatosis after initiation of leptin substitution in a leptin-deficient girl.
von Schnurbein J; Heni M; Moss A; Nagel SA; Machann J; Muehleder H; Debatin KM; Farooqi S; Wabitsch M
Horm Res Paediatr; 2013; 79(5):310-7. PubMed ID: 23651953
[TBL] [Abstract][Full Text] [Related]
19. Leptin and leptin receptor-related monogenic obesity.
Dubern B; Clement K
Biochimie; 2012 Oct; 94(10):2111-5. PubMed ID: 22627381
[TBL] [Abstract][Full Text] [Related]
20. A novel melanocortin 4 receptor (MC4R) gene mutation associated with morbid obesity.
Mergen M; Mergen H; Ozata M; Oner R; Oner C
J Clin Endocrinol Metab; 2001 Jul; 86(7):3448. PubMed ID: 11443223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
